Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Genmab A (GNMSF) Gross Margin (2024 - 2025)

Historic Gross Margin for Genmab A (GNMSF) over the last 2 years, with Q4 2025 value amounting to 114.84%.

  • Genmab A's Gross Margin rose 200400.0% to 114.84% in Q4 2025 from the same period last year, while for Dec 2025 it was 100.0%, marking a year-over-year increase of 45800.0%. This contributed to the annual value of 100.0% for FY2025, which is 45800.0% up from last year.
  • According to the latest figures from Q4 2025, Genmab A's Gross Margin is 114.84%, which was up 200400.0% from 94.32% recorded in Q3 2025.
  • In the past 5 years, Genmab A's Gross Margin ranged from a high of 114.84% in Q4 2025 and a low of 93.84% during Q2 2025